These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 6571441

  • 21. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [Abstract] [Full Text] [Related]

  • 22. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB, Ballenger JC, Rickels K.
    J Clin Psychiatry; 1997 Oct; 58 Suppl 11():11-8. PubMed ID: 9363043
    [Abstract] [Full Text] [Related]

  • 23. Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.
    McCurdy L, Schatzberg AF.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):30-4. PubMed ID: 30765
    [Abstract] [Full Text] [Related]

  • 24. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
    Berkowitz JM.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A, Jiménez-Ferrer E, Zamilpa A, Morales-Valdéz M, García-Valencia CE, Tortoriello J.
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [Abstract] [Full Text] [Related]

  • 26. [Modification of cognitive functions by 2 anxiolytic treatments in patients suffering from generalized anxiety].
    Samuelian JC, Billardon M, Guillou N.
    Encephale; 1995 Jul; 21(2):147-53. PubMed ID: 7781586
    [Abstract] [Full Text] [Related]

  • 27. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR, Sramek JJ, Wardle TS, Hesselink JM, Roeschen JK.
    Psychopharmacol Bull; 1993 Jul; 29(2):303-8. PubMed ID: 7904761
    [Abstract] [Full Text] [Related]

  • 28. Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder.
    Cohn JB, Wilcox CS.
    Pharmacotherapy; 1984 Jul; 4(2):93-8. PubMed ID: 6144090
    [Abstract] [Full Text] [Related]

  • 29. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
    Udelman HD, Udelman DL.
    J Clin Psychiatry; 1990 Sep; 51 Suppl():46-50. PubMed ID: 2211568
    [Abstract] [Full Text] [Related]

  • 30. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
    Tesar GE, Rosenbaum JF, Pollack MH, Herman JB, Sachs GS, Mahoney EM, Cohen LS, McNamara M, Goldstein S.
    J Clin Psychiatry; 1987 Oct; 48 Suppl():16-21. PubMed ID: 3312179
    [Abstract] [Full Text] [Related]

  • 31. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
    Zung WW, Daniel JT, King RE, Moore DT.
    J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
    [Abstract] [Full Text] [Related]

  • 32. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
    Morton S, Lader M.
    Pharmacopsychiatry; 1992 Jul; 25(4):177-81. PubMed ID: 1356277
    [Abstract] [Full Text] [Related]

  • 33. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
    Feltner D, Hill C, Lenderking W, Williams V, Morlock R.
    J Psychiatr Res; 2009 Oct; 43(15):1224-30. PubMed ID: 19423131
    [Abstract] [Full Text] [Related]

  • 34. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH, Starcevic V, Qualls C, Antal EJ, Matuzas W, Javaid JI, Barnhill J.
    Depress Anxiety; 2008 Oct; 25(8):E18-26. PubMed ID: 17960759
    [Abstract] [Full Text] [Related]

  • 35. Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol.
    Kolin IS, Linet OI.
    J Clin Psychiatry; 1981 Apr; 42(4):169-73. PubMed ID: 7009593
    [Abstract] [Full Text] [Related]

  • 36. [Double-blind comparative study of alprazolam (Xanax) and amitriptyline in the treatment of anxiety associated with depression].
    Bernardi F, Cairoli S, D'Aurizio C, De Rosa A, Grasso A, Sannino V, Savoldi F, Sorge F, Casadei GL.
    Minerva Psichiatr; 1988 Apr; 29(4):203-10. PubMed ID: 3074234
    [No Abstract] [Full Text] [Related]

  • 37. Lorazepam in the treatment of neurosis.
    Lameiras JC.
    Curr Med Res Opin; 1976 Apr; 4(6):441-5. PubMed ID: 11961
    [Abstract] [Full Text] [Related]

  • 38. Time-blind videotaped evaluation of injectable diazepam, lorazepam and placebo.
    Bobon DP, Fanielle J, Mormont C, Breulet M, Bobon J.
    Acta Psychiatr Belg; 1978 Apr; 78(4):619-34. PubMed ID: 31063
    [Abstract] [Full Text] [Related]

  • 39. A case of alprazolam, but not lorazepam, inducing manic symptoms.
    Goodman WK, Charney DS.
    J Clin Psychiatry; 1987 Mar; 48(3):117-8. PubMed ID: 3818553
    [Abstract] [Full Text] [Related]

  • 40. Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder.
    Grünberger J, Saletu B, Linzmayer L, Böck G, Weissgram S, Brandstaätter N, Frey R, Saletu-Zyhlarz G.
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):645-54. PubMed ID: 9500129
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.